According to NRC Health 's latest financial reports the company's current EPS (TTM) is $1.19. In 2022 the company made an earnings per share (EPS) of $1.28 a decrease over its 2021 EPS that were of $1.47.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.19 | -7.03% |
2022 | $1.28 | -12.93% |
2021 | $1.47 | -0.68% |
2020 | $1.48 | 12.98% |
2019 | $1.31 | 23.58% |
2018 | $1.06 | 96.3% |
2017 | $0.54 | 10.2% |
2016 | $0.49 | 16.67% |
2015 | $0.42 | -4.55% |
2014 | $0.44 | -8.33% |
2013 | $0.48 | -74.33% |
2012 | $1.87 | -15.06% |
2011 | $2.20 | 72% |
2010 | $1.28 | 0% |
2009 | $1.28 | 15.32% |
2008 | $1.11 | 12.12% |
2007 | $0.99 | 15.12% |
2006 | $0.86 | 16.22% |
2005 | $0.74 | 17.46% |
2004 | $0.63 | 3.28% |
2003 | $0.61 | 12.96% |
2002 | $0.54 | 125% |
2001 | $0.24 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | -$0.06000 | -105.04% | Bahamas |
![]() NRC Health
NRC | $1.19 | 0.00% | ๐บ๐ธ USA |